EP1057024A4 - Methods using pla 2? as a marker of metastases and for the diagnosis of selected cancers - Google Patents

Methods using pla 2? as a marker of metastases and for the diagnosis of selected cancers

Info

Publication number: EP1057024A4
Authority: EP; European Patent Office
Prior art keywords: metastases; pla; marker; diagnosis; methods
Prior art date: 1998-02-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99934342A

Other languages

German (de)

French (fr)

Other versions

EP1057024A1 (en

Inventor

John Burczak

Francis E Wilkinson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Diadexus Inc

Original Assignee

Diadexus Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-23

Filing date

1999-02-12

Publication date

2002-10-30

1999-02-12 Application filed by Diadexus Inc filed Critical Diadexus Inc

2000-12-06 Publication of EP1057024A1 publication Critical patent/EP1057024A1/en

2002-10-30 Publication of EP1057024A4 publication Critical patent/EP1057024A4/en

Status Withdrawn legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Oncology (AREA)
Food Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Biophysics (AREA)
Hospice & Palliative Care (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Enzymes And Modification Thereof (AREA)
Peptides Or Proteins (AREA)

EP99934342A 1998-02-23 1999-02-12 Methods using pla 2? as a marker of metastases and for the diagnosis of selected cancers Withdrawn EP1057024A4 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US111938		1987-10-21
US7550498P	1998-02-23	1998-02-23
US75504P		1998-02-23
US11193898A	1998-07-08	1998-07-08
US17550498A	1998-10-20	1998-10-20
US175504		1998-10-20
PCT/US1999/003170 WO1999042830A1 (en)	1998-02-23	1999-02-12	Methods using pla2 as a marker of metastases and for the diagnosis of selected cancers

Publications (2)

Publication Number	Publication Date
EP1057024A1 EP1057024A1 (en)	2000-12-06
EP1057024A4 true EP1057024A4 (en)	2002-10-30

Family

ID=27372697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99934342A Withdrawn EP1057024A4 (en)	1998-02-23	1999-02-12	Methods using pla 2? as a marker of metastases and for the diagnosis of selected cancers

Country Status (4)

Country	Link
EP (1)	EP1057024A4 (en)
JP (1)	JP3524876B2 (en)
CA (1)	CA2320843A1 (en)
WO (1)	WO1999042830A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL131887A0 (en) *	1999-09-14	2001-03-19	Dpharm Ltd	Phospholipid prodrugs of anti-proliferative drugs
DK1718967T3 (en) *	2004-02-03	2013-06-03	Diadexus Inc	Methods for detecting Lp-PLA2 activity
JP5142288B2 (en) *	2006-04-05	2013-02-13	公立大学法人横浜市立大学	Prognosis determination method for prostate cancer and diagnostic agent therefor
JP5410274B2 (en) *	2006-06-05	2014-02-05	フォースフォトニクスリミテッド	How to characterize an organization

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3743997A (en) *	1996-08-02	1998-02-25	Smithkline Beecham Corporation	A novel method of detecting and treating cancer
US5747264A (en) *	1996-08-02	1998-05-05	Smithkline Beechum Corporation	Method of diagnosing and monitoring prostate cancer

1999
- 1999-02-12 EP EP99934342A patent/EP1057024A4/en not_active Withdrawn
- 1999-02-12 WO PCT/US1999/003170 patent/WO1999042830A1/en not_active Application Discontinuation
- 1999-02-12 JP JP2000532721A patent/JP3524876B2/en not_active Expired - Fee Related
- 1999-02-12 CA CA002320843A patent/CA2320843A1/en not_active Abandoned

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1991, OGAWA M ET AL: "ELEVATION OF SERUM GROUP II PHOSPHOLIPASE A-2 IN PATIENTS WITH CANCERS OF DIGESTIVE ORGANS", XP002212004, Database accession no. PREV199293042492 *
RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, vol. 74, no. 2, 1991, pages 241 - 244, ISSN: 0034-5164 *
See also references of WO9942830A1 *

Also Published As

Publication number	Publication date
EP1057024A1 (en)	2000-12-06
JP3524876B2 (en)	2004-05-10
JP2002511564A (en)	2002-04-16
CA2320843A1 (en)	1999-08-26
WO1999042830A1 (en)	1999-08-26

Publication	Publication Date	Title
GB9707414D0 (en)	1997-05-28	Anatomical probe
EP0804451A4 (en)	1999-09-01	Lung cancer marker
DE69733815D1 (en)	2005-09-01	PROBE FOR EXCAVATION
GB2313914B (en)	2000-08-23	Sub-surface formation fluid tester
GB2318641B (en)	2000-08-16	Measuring borehole geometry
GB9509360D0 (en)	1995-06-28	Replaceable bendable marker
GB9401551D0 (en)	1994-03-23	Marker probe
GB2342863B (en)	2003-02-19	Probe
IL132257A0 (en)	2001-03-19	Selection marker
EP1057024A4 (en)	2002-10-30	Methods using pla 2? as a marker of metastases and for the diagnosis of selected cancers
GB9821975D0 (en)	1998-12-02	New cytotoxic alkaloids
GB9821170D0 (en)	1998-11-25	Marker
GB2346583B (en)	2002-05-22	Security marker
GB9825420D0 (en)	1999-01-13	755273001
PL337368A1 (en)	2000-08-14	13-dihydro-3'-azaridinoantracyclins
GB9708190D0 (en)	1997-06-11	Cancer marker
GB9807604D0 (en)	1998-06-10	The Giraffe
GB9811911D0 (en)	1998-07-29	Technetium separation
GB9613379D0 (en)	1996-08-28	Radiograph marker
AUPP781198A0 (en)	1999-01-21	Improved marker for delineating roadways and the like
AU135750S (en)	1998-11-18	Artist's visual aid
GB2285931B (en)	1998-04-15	Marker
GB9615914D0 (en)	1996-09-11	Imitation rock
TW310838U (en)	1997-07-11	Improved probe cannula
GB9704582D0 (en)	1997-04-23	Marker

Legal Events

Date	Code	Title	Description
2000-10-21	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-12-06	17P	Request for examination filed	Effective date: 20000925
2000-12-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-08-21	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: DIADEXUS, INC.
2002-10-30	A4	Supplementary search report drawn up and despatched	Effective date: 20020918
2002-10-30	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-10-30	RIC1	Information provided on ipc code assigned before grant	Free format text: 7G 01N 33/574 A, 7G 01N 33/53 B
2004-05-19	17Q	First examination report despatched	Effective date: 20040402
2005-03-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-04-20	18D	Application deemed to be withdrawn	Effective date: 20041013